跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIOTEPA HIKMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TIOTEPA HIKMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
TIOTEPA HIKMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Hikma Farmaceutica (Portugal) S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 10, 2025
Approval ID
7793620466d1b073
Company
Hikma Farmaceutica (Portugal) S.A.
Type
Standard
Approval Details
Approval Id
7793620466d1b073
Drug Cima Aemps Name
TIOTEPA HIKMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
90315
Holder Company Name
Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name
Hikma España, S.L.U.
Holder Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Marketing Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Authorization Date
2025-06-10
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
100 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Hikma Farmaceutica (Portugal) S.A.
Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Company Information
Pharmaceutical Company Name
HIKMA FARMACÊUTICA (PORTUGAL), S.A.
Country Name
Portugal
City Name
terrugem snt,lisboa,country_pt
Address
ESTRADA RIO DA MÓ, 8/8A/B
Active Ingredients
TIOTEPA
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 10, 2025
Approval ID
7793620466d1b073
Type
Standard
Back to CIMA-AEMPS Approvals